Nguyen, T. B., Lucero, G. R., Chana, G., Hult, B. J., Tatro, E. T., Masliah, E., . . . Everall, I. P. (2009). Glycogen synthase kinase-3β (GSK-3β) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus–mediated neurotoxicity in primary human neurons.
Chicago Style CitationNguyen, Timothy B., Ginger R. Lucero, Gursharan Chana, Britta J. Hult, Erick T. Tatro, Eliezer Masliah, Igor Grant, Cristian L. Achim, and Ian P. Everall. Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors AR-A014418 and B6B3O Prevent Human Immunodeficiency Virus–mediated Neurotoxicity in Primary Human Neurons. 2009.
MLA CitationNguyen, Timothy B., et al. Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors AR-A014418 and B6B3O Prevent Human Immunodeficiency Virus–mediated Neurotoxicity in Primary Human Neurons. 2009.